Immune Checkpoint Programmed Cell Death Protein-1 (PD-1) Expression on Bone Marrow T Cell Subsets in Patients With Plasma Cell Myeloma.
Min-Young LeeChan Jeoung ParkYoung-Uk ChoEunkyoung YouSeongsoo JangEul-Ju SeoJung Hee LeeDok Hyun YoonCheolwon SuhPublished in: Annals of laboratory medicine (2021)
PD-1 blockade might have therapeutic potential in refractory PCM patients after chemotherapy, especially in those with high- or intermediate-risk cytogenetic abnormalities.